CY1105388T1 - Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα - Google Patents

Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα

Info

Publication number
CY1105388T1
CY1105388T1 CY20061100047T CY061100047T CY1105388T1 CY 1105388 T1 CY1105388 T1 CY 1105388T1 CY 20061100047 T CY20061100047 T CY 20061100047T CY 061100047 T CY061100047 T CY 061100047T CY 1105388 T1 CY1105388 T1 CY 1105388T1
Authority
CY
Cyprus
Prior art keywords
dosage form
pepilamvanusa
therapeutic preparation
pharmaceutical formulation
capsule
Prior art date
Application number
CY20061100047T
Other languages
English (en)
Inventor
Liang C. Dong
Patrick S.-L. Wong
Vincent J. Ferrari
Steven D. Espinal
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of CY1105388T1 publication Critical patent/CY1105388T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Γνωστοποιείται μορφή δοσολογίας περιλαμβάνουσα ημιπερατό περιτοιχισμένο περιέκτη ο οποίος φιλοξενεί καψάκιο, το οποίο καψάκιο περιλαμβάνει φαρμακευτικό σκεύασμα, πιστόνι και οσμωτική σύνθεση. Η μορφή δοσολογίας χορηγεί το φαρμακευτικό σκεύασμα μέσω διόδου με ελεγχόμενο ρυθμό επί χρονική περίοδο βραδείας απελευθέρωσης έως 24 ώρες.
CY20061100047T 1998-09-08 2006-01-16 Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα CY1105388T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9940198P 1998-09-08 1998-09-08
PCT/US1999/020333 WO2000013674A1 (en) 1998-09-08 1999-09-03 Dosage form comprising therapeutic formulation

Publications (1)

Publication Number Publication Date
CY1105388T1 true CY1105388T1 (el) 2010-04-28

Family

ID=22274837

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100047T CY1105388T1 (el) 1998-09-08 2006-01-16 Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα

Country Status (10)

Country Link
US (5) US6551613B1 (el)
EP (1) EP1117383B1 (el)
JP (1) JP2002524151A (el)
AT (1) ATE310508T1 (el)
AU (1) AU6136199A (el)
CY (1) CY1105388T1 (el)
DE (1) DE69928554T2 (el)
DK (1) DK1117383T3 (el)
ES (1) ES2249915T3 (el)
WO (1) WO2000013674A1 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE292453T1 (de) * 1999-12-09 2005-04-15 Alza Corp Antivirale arznei
KR20090007504A (ko) 2000-02-24 2009-01-16 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
MXPA03000073A (es) 2000-06-26 2003-09-25 Monsanto Technology Llc Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina.
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
AU2002359793B2 (en) * 2001-12-19 2007-06-14 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
CA2490412A1 (en) * 2002-06-28 2004-01-08 Alza Corporation Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20040142040A1 (en) * 2002-10-31 2004-07-22 Dong Liang C. Formulation and dosage form providing increased bioavailability of hydrophobic drugs
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AU2004261277A1 (en) * 2003-07-31 2005-02-10 Alza Corporation Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
WO2005030164A2 (en) * 2003-09-26 2005-04-07 Alza Corporation Improved controlled release dosage form including a banded engine
EP1684713A1 (en) * 2003-11-14 2006-08-02 ALZA Corporation Controlled release of topirimate in liquid dosage forms
WO2006011592A1 (ja) * 2004-07-30 2006-02-02 Wakunaga Pharmaceutical Co., Ltd. カプセル皮膜用組成物、カプセル皮膜、及びこれを用いたカプセル剤
US20060165798A1 (en) * 2005-01-27 2006-07-27 Edgren David E Oral osmotic dosage form having a high flux membrane
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CN101232868A (zh) * 2005-04-19 2008-07-30 阿尔扎公司 曲马多和加巴喷丁的控释递药剂型
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
US8764702B2 (en) * 2007-07-05 2014-07-01 Baxter International Inc. Dialysis system having dual patient line connection and prime
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2145643A1 (de) * 2008-07-19 2010-01-20 Markus Storz Portioniertes Arzneimittel
WO2011021594A1 (ja) 2009-08-18 2011-02-24 国立大学法人東北大学 持続性ドラッグデリバリーシステム
EP3323423B1 (en) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
CN102666578A (zh) 2009-12-21 2012-09-12 Ambrx公司 经过修饰的猪促生长素多肽和其用途
EA201290541A1 (ru) 2009-12-21 2013-05-30 Амбркс, Инк. Модифицированные бычьи соматотропиновые полипептиды и их применение
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN104023743B (zh) 2011-10-25 2017-05-03 普罗西纳治疗有限公司 抗体制剂和方法
US9205204B2 (en) 2012-08-06 2015-12-08 Elwha Llc Devices and methods for wearable injection guides
US9550029B2 (en) 2012-10-30 2017-01-24 Elwha Llc Systems and methods for guiding injections
US10046119B2 (en) 2012-10-30 2018-08-14 Elwha Llc Systems and methods for generating an injection guide
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
SG11201810102SA (en) 2016-05-16 2018-12-28 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN111251521B (zh) * 2018-12-03 2022-07-22 沈欣 液态珠丸的制造方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (el) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3905360A (en) 1971-11-01 1975-09-16 Alza Corp Intrauterine device for governing the reproductive process
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111201A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4259323A (en) 1980-03-24 1981-03-31 Hoffmann-La Roche Inc. Potassium chloride emulsion
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
JPS60186385A (ja) 1984-01-30 1985-09-21 不二輸送機工業株式会社 ロボツトハンドの微少移動装置
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4717718A (en) * 1985-08-09 1988-01-05 Alza Corporation Device for the controlled delivery of a beneficial agent
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5236689A (en) * 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US6200600B1 (en) * 1989-02-16 2001-03-13 Btg International Limited Controlled delay release device
US4951494A (en) 1989-10-10 1990-08-28 Alterio Joseph C D Compression rollers with movable shoulder shields
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5633011A (en) 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
WO1996033697A1 (fr) * 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Formulation auto-emulsionnable formant une emulsion huile dans l'eau
CZ299790B6 (cs) * 1996-08-22 2008-11-26 Skyepharma Canada Inc. Kompozice mikrocástic ve vode nerozpustné látky, farmaceutická kompozice, zpusob prípravy stabilních cástic, mikrocástice ve vode nerozpustné nebo slabe rozpustné slouceniny, kompozice obsahující tyto mikrocástice a zpusob prípravy mikrocástic
FR2765608B1 (fr) * 1997-07-04 1999-09-10 Manuf Stephanoise De Transform Dispositif connecteur d'arceaux de tente
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US6445783B1 (en) * 1998-07-14 2002-09-03 At&T Corp. System and method that provides specialized processing of communications based on automatically generated identifiers
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
BRPI0414482B1 (pt) * 2003-09-26 2017-11-21 Disney Enterprises, Inc. Parental control of cell phone access
US20060293057A1 (en) * 2005-06-24 2006-12-28 Mazerski Thomas M System and method for secure web-based mobile phone parental controls
US20080046930A1 (en) * 2006-08-17 2008-02-21 Bellsouth Intellectual Property Corporation Apparatus, Methods and Computer Program Products for Audience-Adaptive Control of Content Presentation
US7996005B2 (en) * 2007-01-17 2011-08-09 Eagency, Inc. Mobile communication device monitoring systems and methods
EP2044943A1 (en) * 2007-10-04 2009-04-08 Solvay Pharmaceuticals, Inc. Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same

Also Published As

Publication number Publication date
US20090130204A1 (en) 2009-05-21
US20080181944A1 (en) 2008-07-31
DK1117383T3 (da) 2006-04-03
US6551613B1 (en) 2003-04-22
US20030157163A1 (en) 2003-08-21
DE69928554T2 (de) 2006-03-30
DE69928554D1 (de) 2005-12-29
EP1117383B1 (en) 2005-11-23
US20100159002A1 (en) 2010-06-24
ATE310508T1 (de) 2005-12-15
EP1117383A1 (en) 2001-07-25
WO2000013674A1 (en) 2000-03-16
AU6136199A (en) 2000-03-27
JP2002524151A (ja) 2002-08-06
ES2249915T3 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
CY1105388T1 (el) Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα
BR0015188A (pt) Composições farmacêuticas
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
CY1105465T1 (el) Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα
DE69100991T2 (de) Pharmazeutische formulierungen.
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
DE60126433D1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
KR970025615A (ko) 암 전이 억제제
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
GEP20043377B (en) Pharmaceutical Complex
DE69300453T2 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
HUP9900504A2 (en) Use of insect pheromones for producing pharmaceutical compositions having antiglucocorticoid effect
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao